Pharmaceutical composition for treating depressive disorder

A composition and technology for depression, applied in the directions of drug combination, pharmaceutical formula, plant raw materials, etc., can solve the problems of limited antidepressant effect of western medicine, inconsistent treatment methods, easy to produce drug resistance and side effects, etc.

Inactive Publication Date: 2016-05-04
JINAN XINGYI MEDICAL TECH
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Western medicine is greatly restricted due to its limited antidepressant effect, susceptibility to drug resistance and side effects
Traditional Chinese medicine has a good curative effect, but because of its complicated pathogenesis, various syndrome types, and inconsistent treatment methods, it still needs further research

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Embodiment 1: the pharmaceutical composition for the treatment of depression and its preparation method

[0035] The composition and parts by weight of the raw material drug of the pharmaceutical composition for treating depression are: 3010g of Eileen, 2315g of cormorant bone, 158g of crotonepoxylin, 158g of emperidin F101g;

[0036] Preparation:

[0037] (1) According to the ratio of raw materials, take Elephant, cormorant bone, crotonoxycin, and sclerophyllin F, mix them evenly, use ethanol with a concentration of 14% by weight as a solvent, and extract them by warm soaking at 45.5°C. The number of times is 14 times, each extraction time is 12.5 hours, and the amount of solvent used each time is 13.5 times of the total weight of the crude drug. After filtering, the medicinal residue A and the extract A are obtained. The extract A reclaims ethanol and concentrates to a relative density of 1.16. Filtration, the medicinal solution passes through the LK08 macroporous ad...

Embodiment 2

[0040] Embodiment 2: the pharmaceutical composition for the treatment of depression and its preparation method

[0041] The composition and parts by weight of the raw material drug of the pharmaceutical composition for treating depression are: 3000g of Eileen, 2330g of cormorant bone, 156g of crotonepoxylin, 156g of emperidin F102g;

[0042] Preparation:

[0043] (1) According to the ratio of raw materials, take Elephant, cormorant bone, crotonoxycin, and sclerophyllin F, mix them evenly, use ethanol with a concentration of 14% by weight as a solvent, and extract them by warm soaking at 45.5°C. The number of times is 14 times, each extraction time is 12.5 hours, and the amount of solvent used each time is 13.5 times of the total weight of the crude drug. After filtering, the medicinal residue A and the extract A are obtained. The extract A reclaims ethanol and concentrates to a relative density of 1.16. Filtration, the medicinal solution passes through the LK08 macroporous ad...

Embodiment 3

[0046] Embodiment 3: the pharmaceutical composition for the treatment of depression and its preparation method

[0047] The composition and parts by weight of the raw material drug of the pharmaceutical composition for treating depression are: 3020g of Ai Lei, 2300g of cormorant bone, 160g of crotonepoxylin, 100g of emperidin F100g;

[0048] Preparation:

[0049] (1) According to the ratio of raw materials, take Elephant, cormorant bone, crotonoxycin, and sclerophyllin F, mix them evenly, use ethanol with a concentration of 14% by weight as a solvent, and extract them by warm soaking at 45.5°C. The number of times is 14 times, each extraction time is 12.5 hours, and the amount of solvent used each time is 13.5 times of the total weight of the crude drug. After filtering, the medicinal residue A and the extract A are obtained. The extract A reclaims ethanol and concentrates to a relative density of 1.16. Filtration, the medicinal solution passes through the LK08 macroporous ad...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a pharmaceutical composition for treating a depressive disorder and a preparation method thereof. The pharmaceutical composition is prepared by taking herba centaurii, cormorant bones, crotepoxide and FTagitininF as bulk pharmaceuticals in proportion. The pharmaceutical composition can be prepared into various preparation forms according to a conventional preparation technology and is significant in depressive disorder treatment effect.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, in particular to a pharmaceutical composition for treating depression and a preparation method thereof. Background technique [0002] Depression is a common affective disorder characterized by significant and persistent low mood and corresponding changes in thinking and behavior. With the development of society and the accelerated pace of work, the incidence of depression is increasing year by year, seriously affecting people's life, work and physical and mental health. Western medicine is greatly limited because of its limited antidepressant effect, easy drug resistance and side effects. Traditional Chinese medicine has a good curative effect, but because of its complex pathogenesis, various syndrome types, and inconsistent treatment methods, it still needs further research. [0003] There is no disease name for depression in Chinese medicine, and similar descriptions are...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/51A61P25/24A61K35/57A61K31/336A61K31/365
CPCA61K36/51A61K9/2031A61K9/2059A61K9/4866A61K31/336A61K31/365A61K35/57A61K2236/333A61K2236/39A61K2236/51A61K2236/53A61K2236/55
Inventor 不公告发明人
Owner JINAN XINGYI MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap